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Graft-infiltrating cells can be cultured from fresh endomyocardial biopsies (EMB) taken after heart
transplantation to determine their growth patterns, phenotypic composition, and functional characteristics
for clinical or scientific purposes. In this study we investigated whether graft-infiltrating cells can also be
cultured successfully after cryopreservation of these EMB. Three different cryopreservation methods were
used. One method gave successful growth in 100% of the cases (n  6): The biopsy fragments were
preincubated in 10% vol/vol dimethyl sulfoxide during 5 min at 07C, frozen to 0707C at approximately
17C per minute, and subsequently immersed and stored in liquid nitrogen. Thawing was performed rapidly
in water at 377C. In addition, the effect of cryopreservation on cell surface phenotype and donor-specific
cytotoxicity of these graft-infiltrating cells was analyzed. When compared to cultures of nonfrozen control
biopsies, both qualities remained constant in most cases, although a variation in CD4//CD8/ cell ratio was
observed in 33% of these cultures. However, when nonfrozen fragments of size-matched biopsies were
cultured separately, a similar variation in phenotype was noted, indicating that this phenomenon can be
attributed to sampling variation and not to the cryopreservation procedure. The present findings suggest
that it is no longer required to culture fresh (nonfrozen) post-transplant EMB to propagate graft-infiltrating
cells: Culturing can be limited to cryopreserved EMB that are selected retrospectively, depending on actual
clinical or scientific interests. Besides greatly facilitating the long-term monitoring of heart transplant
recipients, this also means a substantial decrease in cost and work load for laboratories involved in heart
transplantation. q 1996 Academic Press, Inc.
Endomyocardial biopsies (EMB) are taken selected samples could be thawed and cul-
tured retrospectively depending on actualat regular intervals after heart transplantation
in order to assess the clinical diagnosis of graft clinical and scientific interests.
Cryopreservation of EMB for this purposerejection on a histological basis. In addition,
graft-infiltrating cells can be cultured from has so far not been reported. Therefore, we
investigated in the present study whether insuch EMB and their growth patterns, pheno-
typic composition, and functional characteris- vivo-activated graft-infiltrating cells can be
cultured from cryopreserved post-transplanttics can be determined for clinical or scientific
purposes (4, 12). EMB using three cryopreservation methods.
The conditions that are generally consideredSince routine culturing of every EMB
taken for this purpose is very costly and time- optimal for cryopreservation of human lym-
phocytes (3, 6, 7, 8, 11) were applied in allconsuming, the question was raised whether
biopsies could be cryopreserved without three methods. In the experimental groups we
examined the effect of the preincubationdamaging the growth potential of the graft-
infiltrating cells. If so, all EMB could be (equilibration) of the EMB in cryopreserva-
cryopreserved on a routine basis and only tion medium prior to freezing, and the effect
of culturing the biopsy for a brief period be-
fore freezing, since these variables have been
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tissue fragments such as pancreatic islets were pooled before further analysis was per-
formed. Cell growth of graft-infiltrating cells(1, 9, 10, 13, 14, 16). In addition, phenotypic
characteristics and cytotoxic activity of lym- was considered positive when the yield was
106 cells or more, i.e., the minimal numberphocyte cultures propagated from cryopre-
served biopsies were compared to those of required to perform the phenotypic analysis.
cultures from nonfrozen controls.
Cryopreservation and Thawing
MATERIALS AND METHODS The second half of each biopsy sample was
A total of 20 fresh EMB was obtained from frozen according to one of three different cry-
seven different heart transplant recipients by opreservation protocols.
right ventricular catheterization. The biopsies Method I. The sample was transferred into
were taken at different time points, but no a cryotube with 1 ml RPMI 1640 Dutch modi-
later than 5 months after transplantation. fication containing 10% vol/vol pooled human
Biopsies with approximate size of 2–3 mm3 serum and 10% vol/vol (1.41 M) dimethyl
were used for the experiments. Each fresh bi- sulfoxide at 07C and subsequently frozen in a
opsy was split into two equal parts. The first glasswool-insulated polystyrene container to
half of each biopsy was divided into three 0707C at an average of 17C/min (determined
smaller fragments to facilitate growth of graft- by direct continuous measurement of sample
infiltrating cells. Subsequently these frag- temperature; data not shown), immediately
ments were cultured separately. The second followed by immersion and storage of sample
half of each biopsy was frozen after being tubes in liquid nitrogen (01967C) for a mini-
allocated randomly to one of three different mum of 3 weeks. The sample was thawed
cryopreservation protocols. After thawing, rapidly (in approximately 1 min) by shaking
each sample was divided into three fragments the tube in a water bath of 377C. Directly after
that were cultured separately. thawing the sample was placed in RPMI 1640
containing 10 mg/ml DNAase and 50% human
Culture serum, and subsequently washed twice in
RPMI 1640 with 10% human serum. The sam-Each of the three fragments of the fresh and
the cryopreserved biopsy was placed in one ple was then divided into three fragments that
were subsequently cultured.well of a 96-well round-bottom tissue culture
plate (Costar 3799, Cambridge, MA) with 200 Method II. Freezing and thawing were as
in method I. However, immediately beforeml culture medium and 105 irradiated (40 Gy)
autologous peripheral blood mononuclear freezing the sample was exposed to the cryo-
preservation medium during 5 min at 07C incells (PBMC, isolated by Ficoll–Isopaque
(d  1.077) density-gradient centrifugation) melting ice, instead of transferring the tube
immediately into the 0707C freezer.as feeder cells.
EMB were cultured in RPMI 1640 Dutch Method III. The fresh sample was incubated
(cultured) during 24 h in culture medium, fol-modification (Gibco, Paisley, Scotland) sup-
plemented with 10% vol/vol lectin-free lowed by the protocol applied in Method II.
Lymphocult-T-LF (Biotest GmbH, Dreieich,
Phenotypic AnalysisGermany) as exogenous source of interleukin
2, 10% pooled human serum, 4 mM L-gluta- Surface differentiation antigens of the cultured
graft-infiltrating cells were analyzed by two-mine, 100 IU/ml penicillin, and 100 mg/ml
streptomycin at 377C in a humidified CO2 in- color flow cytometry after staining with mono-
clonal antibodies directed against CD3 (anti-cubator. Half the culture medium was replaced
by fresh medium every 2 to 3 days. leu4) as a pan T-cell marker, the a/b chain of
the T-cell receptor (WT31), and CD4 (anti-leu3)Cells propagated from the three fragments
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TABLE 1and CD8 (anti-leu2) as T-cell subset markers.
Number of Cultures Showing Growth of Graft-Infil-Antibodies were conjugated directly to fluores-
trating Cells from Cryopreserved Post-transplant EMB
cein (FITC) or phycoerythrin (PE) (Becton– Compared to the Number of Growing Cultures from the
Dickinson, Mountain View, CA). Nonfrozen Parts of These EMB, Using Three Different
Cryopreservation MethodsCells were double-stained with two anti-
bodies conjugated to different fluorochromes;
Number of growing cultures105 cells were incubated for 30 min at 47C in
from EMB50 ml Hanks balanced salt solution (Biochrom Cryopreservation
KG, Berlin) with antibodies containing 1% method Nonfrozen Frozen-thawed
bovine serum albumin and 0.1% sodium-
I 4 1 (25%)azide. After washing, cell surface differentia-
II 6 6 (100%)tion antigens were analyzed with a fluores-
III 5 2 (40%)
cence-activated cell scan flow-cytometer
(Becton–Dickinson).
Cell-Mediated Lympholysis (CML)
Spontaneous release was generally 10–15% ofIn a standard 4-h 51Cr-release assay, cyto-
maximal release. An assay was considered posi-toxicity was tested against donor cells and
tive when the percentage of specific lysis ofagainst the K562 cell line for assessment of
donor antigen-bearing target cells exceedednatural killer (NK) and lymphokine-activated
10%. A series of double-dilution studies re-killer (LAK) cell reactivity. Target cells were
vealed that lysis percentages of less than 10%incubated for 1.5 h at 377C in the presence of
are within the variation range of the assay (12).200 mCi 51Cr (Na2CrO4 5 mCi/ml, sp act 350–
600 mCi/mg chromium; Amersham, UK) and RESULTS
subsequently washed. 51Cr-labeled target cells
Generation of Graft-Infiltrating Cell(2.5 1 103) were mixed with effector cells in
Cultureseffector–target ratios from 40:1 to 1.25:1 in
round-bottom tissue culture plates with 0.2 ml Cell growth from nonfrozen (fresh) biopsies
RPMI containing 10% human serum per well. was obtained in 15 out of 20 cases. None of
The plates were centrifuged at 600g for 1 min the frozen counterparts of the five ‘‘non-grow-
and incubated at 377C, and supernatants were ing’’ biopsies did show cell growth. The coun-
collected after 4 h (Skatron AS, Lier, Nor- terparts of the 15 ‘‘growing’’ nonfrozen biop-
way). Spontaneous chromium release was de- sies had been cryopreserved as follows: 4 ac-
termined by incubation of targets in 0.2 ml cording to Method I, 6 according to Method
culture medium, and maximum release was II, and 5 according to Method III. When these
obtained by adding 10% Triton X-100 deter- cryopreserved parts were thawed and cultured,
gent (5% vol/vol solution in 0.01 TRIS buffer) 1 out of 4 biopsies frozen by Method I yielded
to the targets. Experimental, spontaneous, and cell growth (25%), 6 out of 6 biopsies frozen
maximal release were assessed in quadrupli- by Method II resulted in cell growth (100%),
cate. Specific lysis was calculated with the and 2 out of 5 biopsies frozen by Method
following equation: III yielded cell growth (40%) (Table 1). Thus
Methods I, II, and III together yielded a totalSpecific lysis 100%
of 9 biopsies with cell growth from both the
nonfrozen and cryopreserved fragment.
The average time of culture per EMB, be-1
experimental release
0 spontaneous release
maximal release
0 spontaneous release
.
fore the analysis of phenotype and cytotoxic-
ity was performed, was similar for the nonfro-
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TABLE 2zen and the cryopreserved fragments: 6 weeks
Cell Surface Phenotype of Graft-Infiltrating Cell Cul-(4–8), and 7 weeks (5–8), respectively.
tures Propagated from Nine Fragments of Cryopreserved
EMB, Compared to the Cultures Propagated from thePhenotypic Analysis
Nonfrozen Counterparts (Controls)
All nine pairs of cultures propagated from the
Percentage of cells in culturenonfrozen biopsy and its cryopreserved counter-
part were analyzed by flow cytometry. When
Nonfrozen Frozen–thawed
comparing the cultures of the nonfrozen and Phenotype (%) (%)
cryopreserved parts, no differences in phenotype
CD4 91 99were observed in six out of these nine pairs of
CD8 0 0cultures. However, in three cases (33%) the pre-
WT31 neg 0 0dominance of CD4/ or CD8/ cells had shifted
CD4 2* 93*
after cryopreservation, although this occurred in CD8 18* 4*
either direction: Either mainly CD4/ cells were WT31 neg 80 0
CD4 99 98found in the nonfrozen culture and CD8/ cells
CD8 0 0in the frozen–thawed culture, or the reverse was
WT31 neg 0 0found (Table 2).
CD4 95* 3*To test whether these phenotypic differ- CD8 5* 91*
ences were generated by the cryopreservation WT31 neg 0 0
CD4 35* 98*procedure or by sampling variation, we di-
CD8 64* 0*vided 10 size-matched fresh (nonfrozen) biop-
WT31 neg 0 0sies into four fragments each, which were all
CD4 2 0
cultured separately. For comparison with the CD8 98 100
previous experiments, the separate cultures WT31 neg 0 0
CD4 97 95from two fragments were pooled, yielding two
CD8 1 2cell populations from one single biopsy. Sub-
WT31 neg 0 0sequently, phenotypic analysis was per-
CD4 4 3formed. In 7 out of 10 biopsies the cultures CD8 95 96
showed 5% differences in phenotype of one WT31 neg 0 0
CD4 92 100T-cell subset between the homologous coun-
CD8 5 0terparts, indicating that the differences after
WT31 neg 0 0cryopreservation can be attributed to sample
variation (Table 3) and occurred with equal Note. WT31-negative cells consisted of either natural
frequency as in homologous frozen/nonfrozen killer cells of g/d receptor-positive T-cells. In six out
of nine tested pairs of cultures (66%) no differences inEMB counterparts (Fisher’s exact test).
phenotype were observed after cryopreservation. In three
cases (33%) the CD4//CD8/ cell ratio had changedCell-Mediated Cytotoxicity
(marked with *).A cell number sufficient to perform a CML
assay could be propagated in four out of the
nine pairs of cultures that had been analyzed was apparent in the cells from the nonfrozen
biopsy, but not in the culture propagated fromby flow cytometry. In three out of these four
tested pairs of cultures, donor-specific cyto- its cryopreserved counterpart. However, also
in this case the donor-specific reactivity re-toxicity was positive in the culture from both
the nonfrozen and the cryopreserved sample. mained constant in both cultures. Thus donor-
specific cytotoxicity is comparable before andIn the remaining pair no donor-specific lysis
was found in either the nonfrozen or the cryo- after cryopreservation in this study (n  4)
(Table 4).preserved culture. In one biopsy, K562 lysis
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TABLE 3 preservation protocol was successful in 100%
Cell Surface Phenotype of Graft-Infiltrating Cell of the cases.
Cultures from 10 Nonfrozen Post-transplant EMB Each tissue from each species requires spe-
cific cryopreservation conditions for optimalPercentage of cells
per culture functional survival and preservation of cell
structure and characteristics (10). For lympho-
Part I Part II cytes, important variables in this respect in-
Phenotype (%) (%)
clude the kind and concentration of cryopro-
tective agent, the extent of permeation of theCD4 88* 98*
CD8 11 1 cryoprotectant before freezing, the presence
WT31 neg 0 0 and concentration of serum in the cryopreser-
CD4 97 97 vation medium, the freezing and the thawing
CD8 3 2
rate, and the conditions of dilution after thaw-WT31 neg 0 0
ing (17).CD4 59* 18*
CD8 30* 68* For human lymphocytes the optimal cryo-
WT31 neg 9 12 preservation conditions are well established
CD4 16* 7* (3, 6, 7, 8, 11) and these were applied in this
CD8 51* 20*
study in all experimental groups. For EMBWT31 neg 30 73
a cryopreservation protocol has not yet beenCD4 34* 1*
CD8 54* 6* reported. To establish such a protocol for
WT31 neg 11 91 EMB in order to culture graft-infiltrating cells,
CD4 99* 20* we investigated the effect of variables that
CD8 0* 49* have been shown to improve the functionalWT31 neg 0 30
survival of tissue fragments (i.e., pancreaticCD4 68* 82*
CD8 10 15 islets) rather than cell suspensions. One factor
WT31 neg 21 0 that has been reported to improve the func-
CD4 70* 87* tional survival of pancreatic islets is the prein-
CD8 12 10
cubation of the tissue sample in the cryopro-WT31 neg 15 0
tective agent before freezing (equilibration)CD4 100 100
CD8 0 0 (1, 10, 13, 16). This procedure allows deep
WT31 neg 0 0 permeation of dimethyl sulfoxide into the in-
CD4 57 62 tracellular compartments and is therefore
CD8 30 25
WT31 neg 0 13
TABLE 4Note. Each EMB was divided in fragments, which were
Donor-Specific Cytotoxicity of Graft Infiltrating Cellcultured and analyzed separately. WT31-negative cells
Cultures from Cryopreserved Posttransplant EMB, Com-consisted of either natural killer cells or g/d receptor-
pared to the Cultures of the Nonfrozen Counterparts ofpositive T-cells. In 3 out of 10 tested pairs of cultures
these EMB(30%) the CD4/CD8 compositions were identical. In 7
cases (70%) the phenotype had change (marked with *).
Specific lyele
Nonfrozen Frozen-thawed
Biopsy (%) (%)DISCUSSION
EMB 1 29 20The present results show that in vivo-acti-
EMB 2 10 11vated graft-infiltrating cells can be cultured
EMB 3 49 39from cryopreserved endomyocardial biopsies
EMB 4 0 5taken after heart transplantation. One cryo-
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more effective in protecting the cells against showed at least a similar variation (70%), indi-
cating that the observed differences betweenslow freezing injury. The exposure of the sam-
ple to the agent should take place at 07C to nonfrozen and cryopreserved cultures can be
attributed to sampling variation and not to theprevent toxic damage (13). In the present
study we followed the method published by cryopreservation procedure.
Besides sampling variation, dominance ofBank et al. (1), which involved a relatively
brief period of exposure (5 min) of the EMB a particular cell subpopulation as a result of
growth rate differences may also cause varia-to 10% vol/vol dimethyl sulfoxide at 07C prior
to the initiation of freezing, which Taylor et tion in phenotype. However, this phenomenon
is most likely not a significant causal factoral. referred to as the ‘‘partial’’ equilibration
protocol (16). Also, for freezing islets of with respect to the observed variation in phe-
notype in this study, since the average time ofLangerhans such partial equilibration was suc-
cessful in combination with slow cooling culture of the nonfrozen and the cryopreserved
fragments was comparable.(107C) and fast warming (16), as compara-
ble to the protocol used presently. A substantial literature indicates that the
ability of cryopreserved lymphocytes to un-This method appeared to be the most suc-
cessful of the three protocols tested in the dergo blastogenesis in response to antigenic
mitogenic, and allogeneic stimuli is unim-present study: graft-infiltrating cell growth in
cultures of cryopreserved EMBs was observed paired (2, 3, 6, 11, 15). In contrast, the ability
of cryopreserved lymphocytes to perform asin 100% of the cases (Method II). Freezing
without preincubation of the sample in di- cytotoxic effector cells as effectively as their
fresh counterparts is controversial. In accor-methyl sulfoxide yielded cell growth in only
25% of the cases (Method I). This suggests dance with the observations of Dubois et al.
(3), Friedman et al. (5) and Yamada et al. (8),that preincubation of the biopsy in the cryo-
protective agent increases permeation of the but contrary to those reported by others (2,
11), we have demonstrated in the presentcryoprotectant into the tissue sufficiently to
improve cryopreservation of graft infiltrating study that the specific cytotoxicity of graft-
infiltrating cells against donor cells is notcells inside EMB.
Another factor that has been reported to be compromised by cryopreservation when mea-
sured in a standard chromium release assay.beneficial to the functional survival of pancre-
atic islets is prefreezing a culture of tissue In conclusion, this study shows for the first
time that graft-infiltrating cells can be culturedsamples for 1–2 days (9, 14). In the present
study culture of EMBs for 24 h directly before from cryopreserved EMB taken after heart
transplantation. We established a cryopreser-freezing resulted in cell growth in no more
than 40% of the cases (Method III). This pro- vation protocol that was successful in 100% of
the cases. The phenotype and donor-specificcedure therefore did not significantly improve
the yield of graft-infiltrating cells from cryo- cytotoxicity of cultures propagated from cryo-
preserved EMB were comparable to the non-preserved EMBs.
When compared to nonfrozen controls, the frozen controls. Although the total number of
cases tested in this study was relatively small,cell surface phenotype of graft-infiltrating
cells propagated from cryopreserved EMBs these promising results encourage further ex-
periments using this protocol. The presentremained constant in most cases, although a
variation in the CD4//CD8/ cell ratio was ob- findings suggest that culturing of selected
cryopreserved biopsies can be performed ret-served in 33% of the tested cultures. An addi-
tional experiment comparing the phenotypes rospectively depending on actual clinical or
scientific interests. Besides greatly facilitatingof cultures propagated from two nonfrozen
fragments of size-matched biopsies (n  10) the long-term monitoring of heart transplant
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